Impact of a Computerized Clinical Decision Support System to Improve Chronic Obstructive Pulmonary Disease Diagnosis and Testing for Alpha-1 Antitrypsin Deficiency [0.03%]
计算机化临床决策支持系统对慢性阻塞性肺病诊断及抗胰蛋白酶缺乏检测的影响研究
Michael Campos,Brian Hagenlocker,Jorge Lascano et al.
Michael Campos et al.
Rationale: Chronic obstructive pulmonary disease (COPD) and alpha-1 antitrypsin deficiency (AATD) are underrecognized diseases. This is in part due to the underdiagnosis and lack of confirmation of COPD but also from poor adherence to AATD ...
Surya P Bhatt,Arie Nakhmani,Nithin M Thimmegowda et al.
Surya P Bhatt et al.
Rationale: Currently used spirometry measures of airflow obstruction are influenced by demographics, predominantly by age, complicating selection of diagnostic thresholds for the presence of airflow obstruction. Objectives: To develop diagn...
Delays in Recommended Follow-Up after Positive Findings in Lung Cancer Screening [0.03%]
肺癌筛查阳性结果后的推荐随访延迟现象
Alwiya Ahmed,Daniel S Hippe,Madison Snidarich et al.
Alwiya Ahmed et al.
Rationale: Lung cancer screening (LCS) is an effective tool to reduce mortality. However, barriers along the LCS care continuum, including delay in follow-up care, may reduce effectiveness. Objectives: The primary goals of this study were t...
Association of Lung Function Decline with All-Cause and Cancer-Cause Mortality after World Trade Center Dust Exposure [0.03%]
“九一一”尘埃暴露与肺功能减退、全因及癌症死亡率之间的关系
David G Goldfarb,Charles B Hall,Jaeun Choi et al.
David G Goldfarb et al.
Rationale: In numerous cohorts, lung function decline is associated with all-cause and cardiovascular-cause mortality, but the association between the decrease in forced expiratory volume in 1 second (FEV1) and cancer-cause mortality, parti...
A 9-Year Investigation of Healthcare Industry Payments to Pulmonologists in the United States [0.03%]
美国肺科医师接受医药行业付款的9年调查研究
Anju Murayama,Hinari Kugo,Yoshika Saito et al.
Anju Murayama et al.
Rationale: The healthcare industry sometimes makes payments to physicians for nonresearch and research purposes in the United States. Objectives: We aimed to evaluate the trends in nonresearch and research industry payments to pulmonologist...
Effects of Lumacaftor/Ivacaftor on Cystic Fibrosis Disease Progression in Children 2 through 5 Years of Age Homozygous for F508del-CFTR: A Phase 2 Placebo-controlled Clinical Trial [0.03%]
卢卡前列素/伊伐布雷定对F508del-FRT纯合子2-5岁囊性纤维化患儿疾病进展的影响：一项2期安慰剂对照临床试验
Mirjam Stahl,Jobst Roehmel,Monika Eichinger et al.
Mirjam Stahl et al.
Rationale: Lumacaftor/ivacaftor (LUM/IVA) was shown to be safe and well tolerated in children 2 through 5 years of age with cystic fibrosis (CF) homozygous for F508del-CFTR in a Phase 3 open-label study. Improvements in sweat chloride conce...
Trends in Return of Spontaneous Circulation and Survival to Hospital Discharge for In-Intensive Care Unit Cardiac Arrests [0.03%]
心肺复苏后自主循环恢复和住院期间心脏骤停患者出院存活率的改善趋势
Leigh M Cagino,Ari Moskowitz,Brahmajee K Nallamothu et al.
Leigh M Cagino et al.
Rationale: Nearly 3 in 5 in-hospital cardiac arrests (IHCAs) occur in the intensive care unit (ICU), yet large-scale data on the outcomes of in-ICU cardiac arrests have not been published for over a decade. Objectives: We sought to examine ...
Controlled Diesel Exhaust Exposure Induces a Concentration-dependent Increase in Airway Inflammation: A Clinical Trial [0.03%]
可控的柴油尾气暴露浓度依赖性地增加支气管炎症：一项临床试验研究
Juma Orach,Christopher Francis Rider,Agnes Che Yan Yuen et al.
Juma Orach et al.
Rationale: Air pollution exposure is harmful to human airways, and its impacts are best studied using concentration-response relationships. However, most concentration-response research on airway health has investigated chronic exposures, w...
Randomized Controlled Trial
Annals of the American Thoracic Society. 2023 Jun;20(6):834-842. DOI:10.1513/AnnalsATS.202209-762OC 2023
Novel Pulmonary Cyst Characteristics Associated with the Diffusing Capacity of the Lung in Lymphangioleiomyomatosis: A Cross-Sectional Clinical Trial [0.03%]
与淋巴管肌瘤病肺弥散能力相关的新型肺囊特征：横断面临床试验
Brianna P Matthew,Alfredo Lebron,Yun-Ching Chen et al.
Brianna P Matthew et al.